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Abnormal mitochondrial calcium ([Ca2+]m) handling and energy deficiency results in
cellular dysfunction and cell death. Recent studies suggest that nuclear-encoded
microRNAs (miRNA) are able to translocate in to the mitochondrial compartment, and
modulate mitochondrial activities, including [Ca2+]m uptake. Apart from this subset of
miRNAs, there are several miRNAs that have been reported to target genes that play a
role in maintaining [Ca2+]m levels in the cytoplasm. It is imperative to validate miRNAs
that alter [Ca2+]m handling, and thereby alter cellular fate. The focus of this review is to
highlight the mitochondrial miRNAs (MitomiRs), and other cytosolic miRNAs that target
mRNAs which play an important role in [Ca2+]m handling.
Keywords: microRNA, miRNA, mitochondria, MitomiR, mitochondrial calcium, heart failure
INTRODUCTION
One of the cell’s major sources of energy comes from mitochondria. However, the role of
mitochondria is not limited only to ATP generation; mitochondria participate and control
numerous metabolic pathways and signaling cascades, redox balance, β-oxidation of fatty acids, the
synthesis of amino acids, heme and steroids, and cellular apoptosis. The ability of mitochondria to
act as Ca2+ buffer has important consequences on the pattern of the [Ca2+]cyto signals. In addition,
mitochondria are also a major storage hub of cellular calcium (Ca2+), and Ca2+ homeostasis is
fundamental for a wide range of cellular activities such as control of oxidative phosphorylation
(OXPHOS), modulation of cytosolic Ca2+ ([Ca2+]cyto) signals, cell death, secretion, and the
production of reactive oxygen species (ROS) (Mammucari et al., 2018). Approximately 50 years ago
Engstrom et al., demonstrated that mitochondria were able to take up Ca2+(Deluca and Engstrom,
1961), which validated the observation made by Slater and Cleland as early as 1953. In this report,
the authors evaluated the effect of Ca2+ on respiratory activity of heart sarcosomes (previous
nomenclature of mitochondria) (Slater and Cleland, 1953). This work is the basis of future research
in the area of Ca2+-mediated regulation of mitochondrial bioenergetics andmitochondrial calcium
([Ca2+]m) uptake. Additional studies have demonstrated a clear role for [Ca
2+]m as a pleiotropic
signal that regulates many essential functions of cellular physiology. [Ca2+]m concentration is
about 10−7 M and it is the result of the dynamic equilibrium between two continuous and opposite
processes: mitochondrial Ca2+ influx vs. efflux (Granatiero et al., 2017).
The functional relevance of [Ca2+]m in energy processes has been shown in studies that
reflect a positive effect on the tricarboxylic acid (TCA) cycle that increases the synthesis of
reduced substrates (NADH and FADH2), enhances electron transport chain (ETC) activity,
and subsequently increases H+ pumping (Rizzuto et al., 2012). Three mitochondrial matrix
dehydrogenases are activated by Ca2+: α-ketoglutarate (α-KGDH) and isocitrate-dehydrogenases
(ICDH) are regulated by direct binding of Ca2+, while pyruvate dehydrogenase (PDH) is regulated
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by a Ca2+-dependent phosphatase (PDP1) (Glancy and Balaban,
2012; Das et al., 2014). Stimulation of these dehydrogenases
increases NADH and FADH2 availability, which is not only
the central mechanism to provide electron carriers for ATP
production, but also important for regenerating the antioxidative
capacity of the mitochondrial matrix (Nickel et al., 2014). In
addition, Ca2+ activates α-glycerolphosphate dehydrogenase, a
component of the glycerol phosphate shuttle that supplies NAD+
for glycolysis (Wernette et al., 1981). Apart from these proteins,
[Ca2+]m can also modulate the adenine nucleotide transporter
(Mildaziene et al., 1995) and the mitochondrial ATP synthase
(complex V) expression (Das and Harris, 1990), harnessing the
H+ gradient to upregulate ATP production.
It is generally understood that ROS production occurs
through complexes I and III of the electron transport
chain, and by NADPH-oxidase (NOX 4) (Ago et al., 2010).
Additionally, ROS can also be produced by β-oxidation of
fatty acids (Perevoshchikova et al., 2013). It has also been
demonstrated that ROS production is dependent on the activity
of α-glycerolphosphate dehydrogenase (Zorov et al., 2014).
ROS production is directly related to increased [Ca2+]m by
the activation of metabolic fluxes through the TCA cycle, and
increased oxygen consumption by the ETC (Hempel and Trebak,
2017). In fact, there is reciprocal regulation between ROS and
[Ca2+]m signaling, and calcium signaling is essential for ROS
production through activation of mitochondrial dehydrogenases
in the ETC (Görlach et al., 2015). On the other hand, under
physiological conditions, a small amount of H2O2 release from
mitochondria acts as a signal to stimulate physiological Ca2+
release from endoplasmisc reticulum (ER). This happens via the
ryanodine receptors (RyR) which increases [Ca2+]m uptake to
increase ATP production to meet cellular energetic demands
(Camara et al., 2010; Görlach et al., 2015).
Finally, [Ca2+]m also stimulates cell death pathways, such
as apoptosis and necrosis, via activating the intrinsic pathway.
[Ca2+]m overload or mitochondrial depolarization can open
the mitochondrial permeability transition pore (mPTP) (Rasola
and Bernardi, 2011). The mPTP is formed by interactions
between IMM and OMM proteins such as VDAC1, ANT
(adenine nucleotide translocase), and Cyp-D (cyclophilin D),
however, deletion of each one of these proteins does not block
the permeability increase caused by some inducers, indicating
that the mPTP may not be formed by specific proteins, but
just by the interaction between both membranes (Tomasello
et al., 2009). While briefopening and closing of mPTP (more
commonly known as “mitochondrial flickering”) can help to
transient transport [Ca2+]m, complete mPTP openings can result
in release of proapoptotic factors and [Ca2+]m resulting in
apoptosis (Bernardi et al., 2015). When the stress signal results
in simultaneous mPTP opening from several mitochondria, ATP
depletion would result in necrosis (Rasola and Bernardi, 2011).
Abbreviations: miRNA, microRNA; ROS, Reactive Oxygen Species; [Ca2+]m,
Mitochondrial matrix calcium; mt-COX1, Cytochrome C Oxidase subunit
1; COX IV, Mitochondrial respiratory Complex IV; MCU, Mitochondrial
CalciumUniporter; PDH, Pyruvate Dehydrogenase; RISC, RNA-induced silencing
complex; NCX1, Na+-Ca2+ exchanger 1.
Therefore, it is quite evident that [Ca2+]m plays an important
role in both the necrotic and apoptotic cell death pathways. The
role of [Ca2+]m and ROS in apoptosis is particularly important
considering that a small amount of cytochrome c released by
mitochondria can bind and promote the opening of inositol
triphosphate (IP3R) channels. Activated IP3R can release Ca2+
from the ER, which increases [Ca2+]cyto. Consequently, this cycle
further leads to a massive release of cytochrome c, and activation
of caspases and apoptosis (Boehning et al., 2003).
MITOCHONDRIAL CALCIUM TRANSPORT
The mitochondrion is an organelle formed by two different
phospholipid bilayers, an outer mitochondrial membrane
(OMM) that allows the entrance of ions and small proteins
(MW< 10 kDa) and an inner mitochondrial membrane (IMM),
which is ion-impermeable (Mammucari et al., 2018). Calcium
enters the mitochondria through voltage dependent anion
channels (VDAC) in the OMM (Shoshan-Barmatz et al., 2018)
and through the mitochondrial calcium uniporter (MCU)
complex from the IMM using the mitochondrial membrane
potential (19m around −150 to −180mV) as the driving
force generated by the electron transport chain (Liu et al.,
2017). MCU has high Ca2+ affinity and selectivity, enabling
high Ca2+ transport in spite of low [Ca2+]cyto (Kirichok et al.,
2004; Baughman et al., 2011; De Stefani et al., 2011). The
MCU complex is formed by MCU core proteins and several
regulatory proteins such as MCUb, EMRE, MICU1, MICU2,
and MCUR1 (Mallilankaraman et al., 2012; Hajnóczky et al.,
2014; Tomar et al., 2016). Calcium release is mediated by the
Na+/Ca2+ exchanger (NCLX) (Palty et al., 2010) and through
the H+/Ca2+ exchanger (HCX) in tissues where mitochondrial
NCLX activity is low, such as the liver, kidney, lung, and smooth
muscle (Takeuchi et al., 2015). HCX is also known as LETM1
(the leucine zipper-EF hand-containing transmembrane protein
1), but its role as an H+/Ca2+ exchanger or a K+/H+ exchanger
is still controversial (Jiang et al., 2009; Austin et al., 2017). NCLX
activity can be regulated by post-translational modifications,
such as phosphorylation. Alterations in phosphorylation status
in NCLX result in its decreased activity, increased [Ca2+]m
overload, partial mitochondrial depolarization and increased
oxidative stress (Kostic et al., 2015).
THE ROLE OF THE ENDOPLASMIC
RETICULUM
The ER is the main Ca2+ storage location in the cell. There
are overlapping regions between the ER and mitochondria
where highly efficient Ca2+ transfer can occur (Patergnani
et al., 2011). Various pathophysiological conditions increase
the cross-talk between ER and mitochondria. The VDAC-IP3R
interaction is important for [Ca2+]m accumulation (Szabadkai
et al., 2006). Increased sarcoplasmic reticulum (SR)/ER calcium
leakage through RyR or IP3R channels has been implicated in
mitochondrial calcium overload (Santulli et al., 2015; Ivanova
et al., 2017). In fact, RyR or IP3R oxidation by mitochondrial
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ROS increases ER Ca2+ leakage and leads to higher [Ca2+]m
entry (Camara et al., 2010). Protein kinase A (PKA) (Banerjee
and Ghosh, 2006; Gupta, 2017) and GSK-3β (Das et al., 2008)
can regulate VDAC activity by regulating the phosphorylation
status of VDAC. Similarly, another OMM translocator protein
of 18 kDa size, TSPO, has been shown to alter [Ca2+]m intake.
TSPO is capable of complexing with PKA and Acyl-CoA binding
domain containing 3 (ACBD3), recruiting them to the OMM,
which leads to the phosphorylation of VDAC (Gatliff et al., 2017).
Additionally, it has been shown that transient increases in VDAC
expression result in increased [Ca2+]m intake (Rapizzi et al.,
2002).
THE ROLE OF THE MCU COMPLEX
The MCU, a 40 kDa protein, has two transmembrane domains
that need additional interactions to form a functional channel. It
lacks a Ca2+ sensing domain (EF-hand domain), indicating that
Ca2+ regulation capacity is not mediated by MCU (Mammucari
et al., 2018). It has been shown that phosphorylation by CaMKII
can modulate MCU activity (Joiner et al., 2012) as well as other
proteins involved in the complex (Mammucari et al., 2018).
MCU expression and activity may differ between tissues. The
highestMCUmRNA expression levels are seen in skeletal muscle,
followed by the liver, heart, spleen, lung, kidney, brain, and white
fat (Raffaello et al., 2013). MCU activity measured by patch clamp
in isolated mitochondria from mouse hearts, skeletal muscle,
liver, kidney, and brown fat showed that heart mitochondria
exhibited the lowest MCU current. However, this diminished
current could be compensated for by the high numbers of
mitochondria in cardiac muscle (Fieni et al., 2012).
MCUb is a 330 amino acid long protein that shares 50%
similarity with MCU (Raffaello et al., 2013). By studying
the MCU:MCUb interaction using FRET analysis and
immunoprecipitation (IP), Raffaello et al., showed that co-
expression of MCUb with MCU drastically diminishes MCU
activity. (Raffaello et al., 2013).
EMRE (Essential MCU Regulator) is a 10 kDa protein
with a mitochondrial target sequence at the 3’-end. Using in
vitro models such as HEK293T and HeLa cells, the interaction
between EMRE and MCU was identified. Silencing EMRE
abolishes [Ca2+]m uptake (Sancak et al., 2013). Furthermore,
EMRE also facilitates the interaction between MICU1 and
MICU2 with MCU. Cells that lack EMRE have no associations
between MCU and MICU1 or MICU2, while the MCU:MCUb
or MICU1:MICU2 interactions are not affected (Sancak et al.,
2013). Unlike MICU1 or MICU2, EMRE expresses a different
Ca2+ sensing domain directed towards themitochondrial matrix.
Therefore, EMRE modulates MCU activity via [Ca2+]m levels
(Sancak et al., 2013). In fact, EMRE mutation at the Ca2+
sensing acidic motif does not affect MCU complex formation,
but results in increased [Ca2+]m (Kameyama and Gemba,
1991). It is also important to note that the modulatory effect
of EMRE also depends on the [Ca2+]cyto binding affinity
to the MICU1:MICU2 complex (Kameyama and Gemba,
1991). In summary, EMRE plays an important physical and
modulatory role in the formation and activity of the MCU
complex.
MICU1 has two Ca2+ sensing EF-handmotifs directed toward
the intermembrane space (IMS). It has been demonstrated
that MICU1 inhibits [Ca2+]m entry at low resting [Ca
2+]cyto
concentrations (within the range found in cells at rest), protecting
mitochondria from [Ca2+]m overload (Mallilankaraman et al.,
2012; Csordás et al., 2013; Liu et al., 2016). On the other
hand, MICU1 allows for [Ca2+]m uptake when [Ca
2+]cyto
concentrations increase to the micromolar range (Csordás et al.,
2013). This would help mitochondria to rapidly respond to
large [Ca2+]cyto increases (like the one from systolic release).
Interestingly, results from human skin fibroblasts with MICU1
mutations confirmed the gatekeeper role of MICU1 at low
[Ca2+]cyto, but also showed increased [Ca
2+]m uptake at higher
[Ca2+]cyto (Logan et al., 2014). In contrast, MICU2 has been
shown to form a complex with MCU in the presence of MICU1.
MICU2 follows the same pattern of [Ca2+]cyto threshold sensing
as MICU1. MICU2 knock-out cells showed higher [Ca2+]m
uptake at lower [Ca2+]cyto (Kamer and Mootha, 2014). Similarly,
using planar lipid bilayers, Patron et al., concluded that MICU2
plays a gatekeeping role for MCU. MICU2 alters the ratio
between MICU1:MICU2, which allows for the formation of
MICU1-MICU1 dimers, which is responsible for the [Ca2+]m
uptake rate (Patron et al., 2014). Taken together, these MCU
regulatory proteins regulate the rate of [Ca2+]m entry in
response to different [Ca2+]cyto levels. The relative expression
of these MCU regulatory proteins in different tissues, such
as the heart, brain, and skeletal muscle, confers different
mitochondrial calcium handling capabilities (Paillard et al.,
2017).
MITOCHONDRIAL CALCIUM OVERLOAD
IN THE PATHOPHYSIOLOGY OF DISEASE
STATES
[Ca2+]m overload and diminished [Ca
2+]m have both been
linked to the pathophysiology of different disease states.
Particularly, high [Ca2+]m load due to increased SR leakage
through RyR channels has been related to ROS production,
which ultimately leads to heart failure (Santulli et al., 2015).
Human disease conditions, such as proximal myopathy, learning
difficulties, and a progressive extrapyramidal movement disorder,
have also been linked to [Ca2+]m overload (Logan et al.,
2014). Similarly, it has been validated that [Ca2+]m overload
is responsible for excessive ROS production and mitochondrial
depolarization, which results in neuronal death (Saffari et al.,
2017). This mechanism is one of the highlights of Parkinson
disease progression (Kostic et al., 2015; Ammal Kaidery and
Thomas, 2018; Ludtmann and Abramov, 2018).
INFLUENCE OF [CA2+]M IN CANCER
In order to meet the energy demand, cancer cells activate
mitochondrial metabolism. This increased metabolism is
achieved by activation of the TCA cycle dehydrogenases through
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increased [Ca2+]m entry. Considering the up-regulation of
both IP3R and MCU in several types of cancer cells, it seems
that ER/mitochondria communication is key for increased
mitochondrial metabolism and cancer progression (Bustos
et al., 2017). VDAC1 expression is related to poor prognosis in
breast, colon, and lung cancers, where it has been demonstrated
that VDAC1 promotes cell growth by influencing energy
metabolism and inhibiting apoptosis (Mazure, 2017; White,
2017). Additionally, pulmonary arterial cancer cells and colon
cancer cells avoid [Ca2+]m overload through downregulation of
MCU, which confers resistance to cell death (Liu et al., 2017).
Different oncogenes, such as Ras and Akt, have been shown
to regulate apoptosis through modulation of [Ca2+]m entry,
and thus, inhibition of [Ca2+]m overload (Rimessi et al., 2015).
In the same manner, the known tumor suppressor gene, p53,
is capable of interacting with sarco/endoplasmic reticulum
Ca2+-ATPase (SERCA). p53 has been shown to influence the
oxidative state of SERCA, and thus increase SERCA activity in
the ER/mitochondria associated membranes (MAM) fraction.
This is related to increased ER calcium release that results in
[Ca2+]m overload; a priming step for the release of caspase
cofactors—and induction of apoptosis (Giorgi et al., 2015;
Rimessi et al., 2015). Similarly, the tumor suppressor gene, Fhit,
increases MCU affinity toward Ca2+ and induces apoptosis
(Rimessi et al., 2009). Based on this, drugs that increase [Ca2+]m
entry through ER transfer and/or augmented Ca2+ influx can be
used for cancer therapy (Rimessi et al., 2015). However, a strict
balance in [Ca2+]m homeostasis is involved in cancer as Ca
2+
influx is also needed for cellular energy production and cancer
progression (Bustos et al., 2017).
INFLUENCE OF [CA2+]M IN
CARDIOVASCULAR HEALTH
Alterations in calcium handling and the processes regulated by
Ca2+ have been documented in several cardiovascular diseases
(Griffiths, 2009; Kim et al., 2014; Santulli et al., 2015). Santulli
et al., showed increased [Ca2+]m in a heart failure model by
permanent occlusion of the proximal left anterior descending
(LAD) coronary artery (Santulli et al., 2015). In fact, heart failure
is characterized by abnormal [Ca2+]m handling and poor energy
production, which ultimately leads to contractile dysfunction
and myocyte death. This increased [Ca2+]m concentration
was related to mitochondrial dysfunction seen as membrane
depolarization, reduced ATP production, and ROS generation.
In ischemia/reperfusion (IR) injury, both myocytes and whole
hearts are characterized by increased [Ca2+]m uptake resulting in
excessive ROS production and mPTP opening, which ultimately




Understanding some of the key cellular abnormalities in
various disease conditions and developing specific therapies
toward reversing these abnormalities can improve the disease
state. microRNAs (miRNA) represent a large set of master
regulators of gene expression, which can greatly influence
cell death. The binding of miRNAs to their targeted mRNAs
can result in translational repression and/or degradation of
target genes. These miRNAs are predicted to regulate almost
30–40% of mammalian genes (Kim, 2005; Lewis et al.,
2005).
With recent advancements in RNA detecting platforms, we
now can detect miRNAs in the mitochondrial compartment
of cells. The subset of miRNAs, which translocate into the
mitochondria and are functionally active, i.e., RNA-induced
silencing complex, or RISC, is inside the mitochondrial
compartment, are termed mitochondrial miRNA or MitomiR.
The mitochondrial miRNA translocation phenomenon has
not been extensively studied (Macgregor-Das and Das, 2018),
but MitomiRs can influence various mitochondrial functions,
such as the TCA, ETC, lipid metabolism, and amino acid
metabolism (Baradan et al., 2017). It has been demonstrated that
MitomiRs can post-translationally regulate gene function inside
the mitochondrial fraction either by targeting a nuclear-encoded
gene present in the mitochondria or by targeting a mitochondrial
encoded-gene (Das et al., 2012, 2014, 2017). Interestingly, it has
been documented that overexpression of a MitomiR, miR-181c,
in the heart can influence [Ca2+]m handling, highlighting the
role of miR-181c in heart failure (Das et al., 2014). Thus, in this
article, we have focused on the miRNAs that have been found in
the mitochondrial compartment, and target either mitochondrial
or nuclear genes, which ultimately alters [Ca2+]m handling and
cellular fate in different disease conditions.
THE REGULATION OF THE MCU
COMPLEX PROTEINS BY MICRORNAS
Bargaje et al., showed a role for miR-34a and miR-29a in
apoptosis by targeting the 3′-UTR of VDAC1 mRNA in HEK-
293 cells. These miRNAs are dowregulated in hepatocellular
carcinoma and ovarian cancer. However, [Ca2+]m levels were
not documented in this study (Bargaje et al., 2012). Furthermore,
miR-7 has been shown to reduce VDAC1 expression in SH-SY5Y
neuroblastoma cells and mouse primary cortical neurons. This
diminishes Ca2+m efflux, and reduces ROS production, membrane
depolarization, cytochrome c release, and apoptosis, all of which
are factors involved in the development of Parkinson’s disease
(PD) (Chaudhuri et al., 2016). Due to its effects on [Ca2+]m, miR-
7 could potentially be used as a therapeutic agent in the treatment
of Parkinson’s disease. Importantly, miR-7 expression has never
been measured in PD’s patients.
It was proposed from in silico analysis that five miRNAs,
miR-15, miR-17, miR-21, miR-25, and miR-137, could target
MCU and/or MICU1 in tumor cells (Marchi et al., 2013).
However, only miR-25 was able to reduce [Ca2+]m levels
in HeLa cells through MCU downregulation (Marchi et al.,
2013). In both human colon cancer and prostate cancer,
the up-regulation of miR-25 and down-regulation of MCU
protein have been observed. Interestingly, the authors performed
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FIGURE 1 | Mechanism of Action by which miRNAs regulate Ca2+-intake into the Mitochondria.
biochemical assays to demonstrate that miR-25 can directly
bind to the 3’ UTR of MCU mRNA (Marchi et al., 2013).
Treating with antagomiR-25 can increase [Ca2+]m entry and
apoptosis (Marchi et al., 2013). In contrast, in breast cancer
the downregulation of miR-340 is correlated with increased
MCU expression. Targeting MCU, miR-340 increases the rate
of glycolysis, a metabolic shift known as the Warburg effect,
which promotes cell migration and invasion (Yu et al., 2017).
Pulmonary arterial hypertension (PAH) is characterized by
excessive pulmonary artery smooth muscle cell proliferation,
migration, and apoptosis resistance, resulting in a cancer-like
phenotype (Hong et al., 2017). In this model, Hong et al.,
showed decreased expression ofMCUwhich resulted in elevation
of [Ca2+]cyto and reduction in [Ca
2+]m. This was associated
with increased miR-25 and miR-138 expression. Treatment with
antagomiR against both miR-25 and miR-138 can restore MCU
expression levels and reverse the pathophysiology of PAH (Hong
et al., 2017).
Overexpression of miR-25 in the heart protects myocytes
from oxidative damage by reducing [Ca2+]m levels through
downregulation of MCU (Pan et al., 2015). On the other
hand, it has been observed that miR-181c can directly target
the mitochondrial encoded-gene, mt-COX1, which leads to
increased 19m, which could be related to increased [Ca
2+]m
influx and ROS production (Das et al., 2014). Zaglia et al.,
demonstrated a role for muscle-specific miRNAs (myomiR),
such as miR-1 and miR-206, in heart tissue. This group
successfully showed that miR-1 can directly regulate MCU
expression during development in both mouse and human
cardiac myocytes (Zaglia et al., 2017). During the neonatal
phase, i.e., the first few days after birth, mitochondria are
disorganized inside cells. Therefore, in this state the distance
between mitochondria and ER or SR is far apart, and any
Ca2+ release from the ER and/or SR could not influence
[Ca2+]m influx easily. However, by 7–14 days after birth,
the membrane system matures, putting the ER, and/or SR
closer to the mitochondrial membrane (Griffiths et al., 2010).
In this phase, mitochondria are now exposed to ER and/SR
high Ca2+ microdomains, i.e., Ca2+ release from the ER
and/or SR influences [Ca2+]m influx rapidly. Based on the
intracellular location of mitochondria during the neonatal phase,
miR-1 upregulation could protect mitochondria from [Ca2+]m
Frontiers in Physiology | www.frontiersin.org 5 September 2018 | Volume 9 | Article 1291
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overload. This is due to the fact that miR-1 directly targets
the mRNA of MCU (Zaglia et al., 2017). In contrast, during
physiological and pathological hypertrophy where the ATP
consumption rate is higher, downregulation of miR-1, and
increased MCU levels were observed (Zaglia et al., 2017).
Figure 1 summarizes the role of various miRNAs in the in-take
of mitochondrial Ca2+.
OTHER MICRORNAS INVOLVED IN
CALCIUM REGULATION
Other miRNAs have been shown to indirectly regulate [Ca2+]m
overload and/or apoptosis. For example, during hypoxic
conditions downregulation of miR-132 leads to increased Na+-
Ca2+ exchanger 1 (NCX1) expression. Using rat cardiomyocytes
it has been documented that miR-132 could influence [Ca2+]m
overload by binding to the 3′-UTR of NCX1 mRNA and
modulating [Ca2+]cyto (Hong et al., 2015). To release the
intracellular H+ accumulation Na+-H+ exchanger (NHE) gets
activated. Activated NHE release the H+ from the cell at
the cost of Na+ overload. NCX1 plays an important role in
releasing the Na+ from the cells to alleviate the intracellular
Na+-overload. In cardiac hypertrophy, downregulation of
miR-133a has been observed. This leads to higher IP3RII
expression and increased [Ca2+]cyto, resulting in left ventricular
remodeling and contractile dysfunction (Drawnel et al., 2012).
On the contrary, miR-214, which increases its expression
during ischemia/reperfusion (I/R) insult, has been shown to
protect the heart from Ca2+ overload, heart failure, and
apoptosis through targeting NCX1 (Aurora et al., 2012).
Multiple pathophysiological conditions, such as hypertrophy
and I/R, upregulate NCX1 in the heart (Sipido et al.,
2002). Therefore, down-regulation of NCX1 can potentially
be a therapeutic intervention from these pathophysiological
conditions by reducing [Ca2+]cyto overload and cell death. As
it has been shown that miR-214 can directly bind to NCX1
mRNA, increased miR-214 expression can protect the heart
from MI and I/R-stress (Aurora et al., 2012). Indeed, it has
been observed that genetic deletion of miR-214 in mice results
in impaired cardiac function and susceptibility to I/R injury
(Aurora et al., 2012). After I/R, miR-214 significantly reduces
[Ca2+]cyto overload and protects cardiomyocytes from increased
oxidative stress and cell death by reducing NCX1 activity. All
of these effects are directly related to [Ca2+]m (Aurora et al.,
2012). Additionally, overexpression of miR-145 in rat ventricular
cardiomyocytes reduces Ca2+/Calmodulin-Dependent Protein
Kinase II (CaMKII) expression (together with other Ca2+
handling proteins), protecting myocytes from apoptosis induced
by H2O2 (Cha et al., 2013).
As illustrated in Table 1, the miRNAs which are not directly
involved in [Ca2+]m handling, but they play an important role
in buffering [Ca2+]cyto (Shoshan-Barmatz et al., 2018). It has
been shown that the alterations in [Ca2+]cyto could influence
[Ca2+]m influx, either directly by influencing MCU, or indirectly
via other MCU regulatory proteins, such as MICU1. Therefore,
one miRNA can influence [Ca2+]m entry by forming the RISC
inside the mitochondria or at the cytoplasm. If the RISC is inside
themitochondrial compartment, then thatmiRNAwill be termed
as a “MitomiR.”
CONCLUDING REMARKS
[Ca2+]m is regulated by its influx and efflux through VDAC, the
MCU complex, NCXL, and NHX. Therefore, the regulation of
these Ca2+-sensing proteins can determine the fate of cellular
activity. Recent studies have highlighted the importance of
MitomiR on [Ca2+]m handling and mitochondrial function,
making these MitomiRs attractive as therapeutic targets. While
there is still much work to be done with regards to miRNA
import into the mitochondria, several groups have documented
that MitomiRs can regulate [Ca2+]m entry. The potential for
miRNA therapeutics is limitless, and could be applied to any
disease, including Alzheimers, Parkinson’s, cancer, and heart
failure, which are characterized by alterations in their MitomiR
profiles. Indeed, it is true that when researchers across the world
tried to regulate [Ca2+]m by knocking down MCU protein in
a mouse model, there were very conflicting results. In some
studies, cardio-specific MCU knock-out proved detrimental
against various stresses, such as ischemia/reperfusion injury.
On the other hand, global MCU knock-out mice showed a
minimal functional effect. MCU knock-out mice are slightly
smaller compared to their wild type littermates and the mice
have modest defects in skeletal muscle strength and some
alterations in metabolic functions. Apart from these minor
phenotypical defects, the global MCU knock-out mice are
healthy. Therefore, alteration of MCU to regulate [Ca2+]m
will require extensive studies to fully uncover the underlying
molecular mechanism(s) before proposing that a miRNA for
regulating the MCU gene could be an effective strategy to
achieve a therapeutic goal. However, the gate-keeper of MCU,
MICU1, when altered showed very consistent outcomes in
multiple groups. It is known that knocking down MICU1 is
detrimental when [Ca2+]cyto is low, whereas knocking-down
MICU1 is beneficial when [Ca2+]cyto is high. Studies have
clearly shown that it is the ratio between MICU1 and MICU2
that plays a pivotal role in [Ca2+]m influx. Therefore, it is
fair to predict that miRNA(s) which can effectively bind to
MICU1 and/or MICU2 mRNAs can influence the [Ca2+]m. In
particular, there is great potential for treatment of conditions
such as diabetes and cardiovascular disease with MitomiR(s)
manipulation due to their impact on the mitochondria and
overall cardiac function.
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